Agilent Technologies Cash Flow from Operating Activities 2010-2024 | A

Agilent Technologies annual/quarterly cash flow from operating activities history and growth rate from 2010 to 2024. Cash flow from operating activities can be defined as a company's cash flows from operations.
  • Agilent Technologies cash flow from operating activities for the quarter ending January 31, 2024 was $0.485B, a 63.85% increase year-over-year.
  • Agilent Technologies cash flow from operating activities for the twelve months ending January 31, 2024 was $4.207B, a 39.77% increase year-over-year.
  • Agilent Technologies annual cash flow from operating activities for 2023 was $1.772B, a 35.06% increase from 2022.
  • Agilent Technologies annual cash flow from operating activities for 2022 was $1.312B, a 11.65% decline from 2021.
  • Agilent Technologies annual cash flow from operating activities for 2021 was $1.485B, a 61.24% increase from 2020.
Agilent Technologies Annual Cash Flow Ops
(Millions of US $)
2023 $1,772
2022 $1,312
2021 $1,485
2020 $921
2019 $1,021
2018 $1,087
2017 $889
2016 $793
2015 $512
2014 $731
2013 $1,152
2012 $1,228
2011 $1,260
2010 $718
2009 $408
Sector Industry Market Cap Revenue
Computer and Technology Electrical Test Equipment $45.318B $6.833B
Agilent Technologies, Inc. is an original equipment manufacturer of a broad-based portfolio of test and measurement products serving multiple end markets. Recently, the company has diversified into new end markets, namely industrial, chemical and electronics markets. The company has three business segments, including Life Sciences & Applied Markets Group (LSAG), Diagnostics and Genomics Group (DGG) and Agilent Cross Lab Group (ACG).The company uses a direct sales model for the distribution of its products, which is supplemented by distributors, resellers, manufacturers' representatives, telesales and electronic commerce, as necessary.
Stock Name Country Market Cap PE Ratio
AMETEK (AME) United States $39.026B 25.82
Fortive (FTV) United States $27.155B 21.98
Teradyne (TER) United States $21.779B 48.27
Cognex (CGNX) United States $8.327B 83.64
Itron (ITRI) United States $5.029B 26.74